Sonova Holding AG, trading under the symbol SONVY on the OTCMKTS, is a Switzerland‐based global leader in the design, manufacture and distribution of hearing care solutions. Since its founding in 1947, Sonova has focused on developing innovative hearing instruments and implantable devices to improve auditory function and quality of life for individuals with hearing loss. The company’s core business activities encompass research and development, manufacturing, sales and after‐sales services within the audiological care sector.
Sonova’s product portfolio is organized across two main segments. The Hearing Instruments division includes well‐known brands such as Phonak, Unitron and Hansaton, which offer a range of behind‐the‐ear, in‐the‐ear and custom hearing aids. Its Cochlear Implant Systems division, operating under the Advanced Bionics brand acquired in 2009, provides implantable devices and sound processors designed for individuals with severe to profound hearing impairment. Beyond product sales, Sonova offers fitting, support and repair services through an extensive network of audiology clinics, retail partners and distribution centers, ensuring comprehensive patient care from initial consultation through long‐term follow‐up.
With operations in over 100 countries, Sonova serves markets in Europe, North America, Asia‐Pacific, Latin America and the Middle East. The company maintains regional manufacturing facilities and research centers in Switzerland, Germany, the United States and China, alongside a global network of sales affiliates and authorized providers. Strategic acquisitions and partnerships have broadened Sonova’s geographic reach and strengthened its direct‐to‐consumer channels, reinforcing its position as a market leader in hearing healthcare.
Sonova’s leadership team, led by CEO Arnaud Nicoletti and supported by an experienced executive board, places strong emphasis on innovation, quality and corporate responsibility. The company invests a significant portion of revenues into R&D, focusing on advanced digital signal processing, wireless connectivity and miniaturization technologies. This commitment to technological advancement and patient‐focused service has underpinned Sonova’s growth and reputation as a trusted provider in the competitive global audiology industry.
AI Generated. May Contain Errors.